Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-12-22

Clinical Trial Update: Symptomatic Treatment of Distal Tubercle Fractures of the Scaphoid

View source ↗

Summary

The trial investigating symptomatic treatment for distal tubercle fractures of the scaphoid has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Distal Tubercle Fractures of the Scaphoid | Status: WITHDRAWN